Anna Golebiewska

Latest publications

Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes.

  • NORLUX Neuro-Oncology Laboratory
November 01, 2015
2015 Nov. FASEB J.29(11):4695-712. Epub 2015 Jul 28.
By:
  • Burtey A
  • Wagner M
  • Hodneland E
  • Skaftnesmo KO
  • Schoelermann J
  • Mondragon IR
  • Espedal H
  • Golebiewska A
  • Niclou SP
  • Bjerkvig R
  • Kogel T
  • Gerdes HH.
Read publication

Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.

  • NORLUX Neuro-Oncology Laboratory
  • Platform LUXGEN - Micro-Array
May 01, 2015
2015 May. PLoS One.10(5):e0123544.
By:
  • Sanzey M
  • Abdul Rahim SA
  • Oudin A
  • Dirkse A
  • Kaoma T
  • Vallar L
  • Herold-Mende C
  • Bjerkvig R
  • Golebiewska A
  • Niclou SP.
Read publication

OECI-EACR precision medicine for cancer: Conference report 1-4 March 2015, Luxembourg.

  • NORLUX Neuro-Oncology Laboratory
April 03, 2015
2015 Apr. ecancermedicalscience.9:519.
By:
  • Golebiewska A
  • Fritah S
  • Girotti MR.
Read publication

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.

  • NORLUX Neuro-Oncology Laboratory
  • Translational Radiomics
January 01, 2015
2015 Jan. Acta Neuropathol.129(1):115-31. Epub 2014 Oct 17.
By:
  • Fack F
  • Espedal H
  • Keunen O
  • Golebiewska A
  • Obad N
  • Harter PN
  • Mittelbronn M
  • Bahr O
  • Weyerbrock A
  • Stuhr L
  • Miletic H
  • Sakariassen PO
  • Stieber D
  • Rygh CB
  • Lund-Johansen M
  • Zheng L
  • Gottlieb E
  • Niclou SP
  • Bjerkvig R.
Read publication

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.

  • NORLUX Neuro-Oncology Laboratory
May 08, 2014
2014 May. Cancer Med.3(4):812-24. Epub 2014 May 8.
By:
  • Torsvik A
  • Stieber D
  • Enger PO
  • Golebiewska A
  • Molven A
  • Svendsen A
  • Westermark B
  • Niclou SP
  • Olsen TK
  • Chekenya Enger M
  • Bjerkvig R.
Read publication

Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.

  • NORLUX Neuro-Oncology Laboratory
  • Platform National Cytometry
  • Platform LUXGEN - Micro-Array
February 01, 2014
2014 Feb. Acta Neuropathol.127(2):203-1. Epub 2013 Oct 24.
By:
  • Stieber D
  • Golebiewska A
  • Evers L
  • Lenkiewicz E
  • Brons NH
  • Nicot N
  • Oudin A
  • Bougnaud S
  • Hertel F
  • Bjerkvig R
  • Vallar L
  • Barrett MT
  • Niclou SP.
Read publication

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.

  • NORLUX Neuro-Oncology Laboratory
September 01, 2013
2013 Sep. Neuro Oncol.15(9):1200-11. Epub 2013 May 30.
By:
  • Johansson M
  • Oudin A
  • Tiemann K
  • Bernard A
  • Golebiewska A
  • Keunen O
  • Fack F
  • Stieber D
  • Wang B
  • Hedman H
  • Niclou SP.
Read publication

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.

  • NORLUX Neuro-Oncology Laboratory
  • Platform National Cytometry
  • Platform LUXGEN - Micro-Array
May 01, 2013
2013 May. Brain.136(Pt 5):1462-75. Epub 2013 Mar 4.
By:
  • Golebiewska A
  • Bougnaud S
  • Stieber D
  • Brons NH
  • Vallar L
  • Hertel F
  • Klink B
  • Schrock E
  • Bjerkvig R
  • Niclou SP.
Read publication

Critical appraisal of the side population assay in stem cell and cancer stem cell research.

  • NORLUX Neuro-Oncology Laboratory
  • Platform National Cytometry
February 01, 2011
2011 Feb. Cell Stem Cell.8(2):136-47.
By:
  • Golebiewska A
  • Brons NH
  • Bjerkvig R
  • Niclou SP.
Read publication